Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors

Launched by XIJING HOSPITAL · Jul 23, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help doctors tell the difference between benign (non-cancerous) and malignant (cancerous) liver tumors without needing invasive procedures like surgery or biopsies. The goal is to find a safe and effective method that can help make this distinction using imaging techniques.

To participate in the trial, you need to be between 18 and 70 years old and have a liver tumor that can be seen using a standard ultrasound. You should also have had a liver examination before any biopsy or surgery. The study is currently recruiting participants, and all genders are welcome. If you decide to join, you can expect to undergo some routine tests and imaging, which will help researchers gather important information about your condition. It's important to note that this trial cannot accept individuals with certain conditions, such as those who have had previous liver surgeries or treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • (1) age 18-70 years; (2) liver examination performed for all patients prior to US-guided liver biopsy or surgery; (3) tumor can be visualized in conventional US; (4) largest tumor sectional area saved in DICOM format for use in later analyses; (5) a histopathological diagnosis made either from US-guided liver biopsy or surgical resection; (6) suitable routine clinical and US data obtained within 7 days of the histopathological diagnosis.
• Exclusion Criteria:
• • (1) unavailable pathological diagnosis; (2) liver metastatic tumors; (3) poor quality US images; and (4) a past history of surgical resection, percutaneous local ablation, radiation, transarterial and systemic therapies or liver transplantation.